All News

unhappy%20patient.jpg

DMARD Dropouts During COVID-19

d Jack Cush, MD

A full year from the onset of the SARS-COV-2 pandemic, rheumatologists are still seeing the consequences of COVID, with many patients avoiding usual care, follow-up visits, routine lab testing and with many self-stopping their antirheumatic meds, because it seemed like the right thing to do.

Read Article
food healthy unhealthy beer alcohol salt

Anti-inflammatory Diet Control of Rheumatoid Arthritis

d Jack Cush, MD

The TOMORROW study assessed the relationship between diet and disease activity in rheumatoid arthritis (RA) patients and has shown that RA patients are more likely to have higher inflammatory diets, but that a change to an anti-inflammatory diet resulted in lower disease activity s

Read Article
RheumNow Podcast square

RheumNow Podcast – Mistakes with Steroids

d Jack Cush, MD

Dr Jack Cush gives his spin on this week's RheumNews and Rheum Research from RheumNow.com.

Read Article
News Feature: GLP-1 Therapy in Knee Osteoarthritis Knee osteoarthritis (KOA) is best managed by weight loss, as the effects of most analgesic therapies have been marginal and debatable. https://t.co/0YB5rOuJiD #RheumNow https://t.co/LEFUBTlJq4

Links:

Dr. John Cush RheumNow ( View Tweet)
Med nonadherence is universal 1) at 1 yr, only 48% pts still take their statins, 2) 1 in 4 pregnant asthmatics dont take their inhaled corticosteroids,. 3) half of psychiatric pts don’t take their psychotropic meds. What are the reasons for noncompliance? https://t.co/OBAfbFLIO9

Links:

Dr. John Cush RheumNow ( View Tweet)

Study of 26 patients with chronic inflammatory cdiseases vaccinated with mRNA vaccines showed all with considerable immunogenic responses. No unexpected side effects seen and No flares of the underlying inflammatory disease was seen. https://t.co/7Q5bYp5A9i

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Overview of New VEXAS Syndrome Medscape offers up an informative overview of the newly described syndrome called VEXAS discovered by researchers at the National Institutes of Health. https://t.co/9oDtahJ9yI #RheumNow https://t.co/5yBiiRPWb3

Links:

Dr. John Cush RheumNow ( View Tweet)
RT from @KDAO2011"When Ustekinumab was developed, it was accidental that the p40 subunit targeted blocked both IL-12 and IL-23 (original intent to block only IL23) blocking I12 may decrease response to IL-23. this drug is better for skin than for joints - Dr. E Ruderman #RNL2021

Dr. John Cush RheumNow ( View Tweet)

News Feature: Can Targeting RANKL in RA Heal Erosions? Treatment with denosumab (Prolia) helped heal bone erosions over 2 years among patients with rheumatoid arthritis whose disease activity was well controlled, researchers reported. https://t.co/kpYozqR8vD #RheumNow https://t.co/m0SjJzfp8m

Links:

Dr. John Cush RheumNow ( View Tweet)
RT from @doctorRBC covering #RNL2021 -------- Make sure to screen your PsO and PsA for depression and mental health. Worsening depression can cause emotional stress, leading to worse disease. #RNL2021 #rheumnow

Dr. John Cush RheumNow ( View Tweet)

News Feature: Implementing Smoking Cessation Programs #RheumNow https://t.co/wEBZRd3n8Q https://t.co/c5yfIyl2Vc

Links:

Dr. John Cush RheumNow ( View Tweet)
#RNL2021 Tweet from @uptoTate 2020 (contact) allergen of the year: Essential Oils! Keep on using 'em in order to put your family-friendly dermatologist's kids through school! Melodie Young, NP #RNL2021

Dr. John Cush RheumNow ( View Tweet)

11 RCTs (4,329 pts) & 19 registries (9,739 pts) studied Rx efficacy in CTD pts w/ pulmonary HTN. Overall, Rx (Sildenafil, Treprostinil, Bosentan, etc) reduced mortality 36% vs controls. CTD‐PAH survival was lower (52% v 72%) vs PAH; higher after 2010 https://t.co/IFb3nLiJbL

Links:

Dr. John Cush RheumNow ( View Tweet)

New podcast available--Mistakes with Steroids Dr Jack Cush gives his spin on this week's news featured on RheumNow. Download wherever podcasts are available. https://t.co/cUI65I9759 https://t.co/fOWJXW50nI

Links:

Dr. John Cush RheumNow ( View Tweet)
HLA-B27 status does not change the risk of COVID-19 in spondyloarthritis patients. Survey of 3435 SpA pts; shows 76% as HLA-B27 positive. COVID infx was thesame between B27 Pos & Neg pts (1.5% vs 1.4%) and severity was also the same https://t.co/qavodFynr0

Links:

Dr. John Cush RheumNow ( View Tweet)

Axial Involvement in SpA: A Patient-Centered Exploration Sponsored by Novartis Medical Affairs Listen to Ethan Craig, MD, MPH present insights from patient cases to distinguish axial involvement within the spectrum of SpA. https://t.co/o2q5pTP3WD https://t.co/IXHs0LHSOe

Links:

Dr. John Cush RheumNow ( View Tweet)
#RNL2021 coverage from @DrPetryna Refractory RA by Dr. Buch: -active DZ after >2 b/ts DMARDs -why rfRA exists: ?Immunologic heterogeneity of RA ?contributing co-morbidities ?unidentified Rx target -effective Rx in early disease decreases risk of future rfRA" https://t.co/ecrbqlvemf
Dr. John Cush RheumNow ( View Tweet)
News Feature: Rheumatology Care Derailed by COVID-19 A survey study from the ArthritisPower PPRN or CreakyJoints database shows that during the COVID-19 pandemic patient care was substantially affected in unforeseen ways. https://t.co/BqY0vJpdm8 https://t.co/nZcuL4FbEw

Links:

Dr. John Cush RheumNow ( View Tweet)
Don’t underestimate the utility of Vitamin D for VTE ppx in APS patients. Everyone should get some sun #RNL2021 Coverage from @doctorRBC #RheumNow

Dr. John Cush RheumNow ( View Tweet)

Top March Tweet: The FDA approved tocilizumab for use in Systemic Sclerosis-Associated Interstitial Lung Disease for "Slowing the rate of decline in pulmonary function in adult patients with SSc-ILD" Rec dose is 162 mg SC q week (IV dose not approved) https://t.co/HXTRPiYEfZ

Links:

Dr. John Cush RheumNow ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×